Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

SU101: Discontinued Phase III trial

April 10, 2000 7:00 AM UTC

Pharmacia Corp. (PHA), Peapack, N.J. Product: SU101 Business: Cancer Therapeutic category: Signal transduction, Cell proliferation Target: PDGF receptor Description: Small molecule inhibitor of plate...